Search CTSO
Cytosorbents Corp
Nasdaq · CIK 1175151
Last close4.05
Daily change-0.13 (-3.23%)
10 Years gain-96.99%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
CTSO · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
40.7Momentum
n/aAcceleration
n/aConfidence
65.0Annual Revenue8
Quarterly Revenue35
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet1.2 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Key Metrics
Revenue Growth TTM36.31%OK
Revenue CAGR 3Y67.47%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $26.49M | -$14.75M | -$12.38M | -$12.54M | n/a | n/a | n/a | -61.09% | 62.23M |
| 2025 FY Dec 31, 2024 | n/a | $24.89M | -$16.45M | -$14.43M | -$14.71M | n/a | n/a | n/a | -71.78% | 54.43M |
| 2024 FY Dec 31, 2023 | n/a | $21.95M | -$31.95M | -$21.66M | -$22.19M | n/a | n/a | n/a | -154.74% | 44.66M |
| 2023 FY Dec 31, 2022 | n/a | $20.73M | -$31.52M | -$28.23M | -$34.32M | n/a | n/a | n/a | -173.71% | 43.57M |
| 2023 FY Dec 31, 2021 | n/a | $32.12M | -$22.74M | -$14.01M | -$17.65M | n/a | n/a | n/a | -197.08% | 43.36M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $30.67M | sum latest 4 fiscal quarters Revenue | OK | 0001144204-19-024246, 0001144204-19-037883 |
| Revenue Growth TTM | 36.31% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001144204-19-024246, 0001144204-19-037883 |
| Revenue CAGR 3Y | 67.47% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001144204-19-012774 |
| Revenue CAGR 5Y | 56.17% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001144204-19-012774 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-092006 |
| Current Ratio | 0.66x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.26x | (Cash + Short-term Investments) / Total Debt | OK | 0001104659-26-092006 |
| Revenue per Diluted Share | $0.49 | Revenue / Diluted Shares | OK | 0001144204-19-024246, 0001144204-19-037883 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001104659-26-092006 |